(Q60022018)

English

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

scientific article published on 01 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

recurrent small cell lung cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Marcus Neubauer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Melvin Moore

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Matthew W Harding

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Corey J Langer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Helen J Ross

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bruce E Johnson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Thomas J Lynch

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

924-932

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to multidrug resistance reversal.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug resistance transporters and modulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant gene expression in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22492

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22492

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17285598%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60022018&oldid=1531098601"